Crescita Therapeutics Inc. (TSX:CTX)

Revenue by Segment

Financials in millions CAD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Commercial Skincare	12.21M	11.44M	10.44M	8.02M	7.47M
Licensing and Royalties	1.77M	1.25M	2.03M	1.80M	3.97M
Manufacturing and Services	7.13M	6.89M	5.05M	13.70M	5.33M
Total	21.12M	19.58M	17.52M	23.53M	16.77M

Revenue by Geography

Financials in millions CAD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Canada	12.76M	11.86M	11.73M	9.79M	9.63M
United States	3.79M	5.00M	4.18M	12.14M	4.75M
Rest of The World (ROW)	4.57M	2.72M	1.62M	1.60M	2.39M
Total	21.12M	19.58M	17.52M	23.53M	16.77M

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 7, 2026

Data Sources Report a data error